Results 231 to 240 of about 182,622 (382)

Inhibitory Effects of the Bone-Derived Growth Factors Osteoinductive Factor and Transforming Growth Factor-β on Isolated Osteoclasts*

open access: bronze, 1990
Richard O. C. Oreffo   +6 more
openalex   +1 more source

Conditions that Support Long‐Term Production of Osteoclast Progenitors In Vitro [PDF]

open access: bronze, 1997
Minako Y. Lee   +3 more
openalex   +1 more source

Advances in miRNA research: Unraveling the complexities of gene regulation

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Overview of miRNA‐mediated regulation in key biological processes. This illustration offers a comprehensive view of the diverse functions that microRNAs perform in governing various biological processes, highlighting their profound significance within the complex web of gene expression and cellular function.
Jiawei Zheng, Guoqing Zhang, Linzhu Ren
wiley   +1 more source

Atypical fibroxanthoma with osteoclast-like giant cells.

open access: hybrid, 1994
J. Fernando Val‐Bernal   +3 more
openalex   +2 more sources

Vitamin D‐induced mechanisms in cancer prevention and therapy: Recent advances and future opportunities

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Vitamin D, traditionally known to promote calcium and bone health, is being explored for its role in cancer prevention and treatment through its influence on cell proliferation, differentiation, apoptosis, and immune response. The vitamin D receptor (VDR) regulates gene expression and interacts with key signaling pathways such as Wnt/β‐catenin, MAPK ...
D. Prasanth   +10 more
wiley   +1 more source

Alendronate Alters the Release of EVs by Raw 264.7 Osteoclasts. [PDF]

open access: yesJ Histochem Cytochem
Faria LP, Arana-Chavez VE, Holliday LS.
europepmc   +1 more source

Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease

open access: yesAdvanced NanoBiomed Research, EarlyView.
Peptide/antibody–drug conjugates (PADCs) combine ligand specificity and cleavable linkers to deliver drugs precisely to disease sites with minimal toxicity. While current approvals focus on oncology, this review examines their untapped potential in inflammatory diseases, detailing mechanisms of targeted delivery and highlighting advances that position ...
Yeongji Jang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy